Skip to main content
Jonathan Grinstein on Muck Rack

Jonathan Grinstein

Verified
San Diego
As seen in: Behind the Breakthroughs, Inside Precision Medicine, SAGE Publishing, Medium, Frontiers, Scientific American, Flipboard, Pocket, Salon, Mary Ann Liebert, Inc., EIN News, NewsBreak, Genetic Engineering & Biotechnology News and
Scientist turned storyteller. North American Editor @inside_pm. for story leads: jonathan.grinstein@sagepub.com

Get in touch with Jonathan

Contact Jonathan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Sweet Caroline: BCIs That Restore Sensation of Touch Show Long-Term Safety

|
By Jonathan Grinstein Verified
| Inside Precision Medicine Verified
Credit: Yana Iskayeva / Getty Images / Moment “Touching hands, reaching out, touching me, touching you.” The lead up to the chorus of Neil Diamond’s “Sweet Caroline” has become a ritual in stadiums and bars across America, celebrating one of the most universal human experiences: reaching out to touch another person. For people living with paralysis after a spinal cord injury, that experience often disappears.
Open in Who Shared Issue with article?

Ephphatha! When a $1M Deafness Cure Comes at No Cost

|
By Jonathan Grinstein Verified
| Inside Precision Medicine Verified
Travis Smith and his mother Sierra [Michs Pics Photography] “Can you say hi? He’s saying something!” For most new parents, that’s an interaction—you get the baby’s attention, and the baby babbles back—that is expected to happen. For Sierra, that never happened with her son, Travis. Born six weeks early, Travis spent about a week in the NICU. To get out of the NICU, he had to pass a newborn hearing test. Only Travis didn’t pass.
Open in Who Shared Issue with article?

Amit Etkin: Precision Psychiatry’s Future Isn’t Genomics—It’s Brain Activity

|
By Jonathan Grinstein Verified
| Inside Precision Medicine Verified
Credit: J Studios / Getty Images / DigitalVision For decades, psychiatry has used trial-and-error symptom-based diagnoses and treatments. Standardized diagnostic frameworks brought much-needed consistency to the field, but they also grouped diverse patients with different biology. Consequently, many people receive unsuitable treatments. On this episode of Behind the Breakthroughs, Alto Neuroscience founder and CEO Amit Etkin, MD, PhD, discusses how precision medicine will change mental health care.
Open in Who Shared Issue with article?
See all 784 articles